Unlocking therapeutic value.
Unlocking therapeutic value.
We help biotech and pharma teams make smarter drug development decisions using Quantitative Medicine strategies.
By translating data into actionable insights through quantitative modeling, we reduce uncertainty, accelerate development, and build regulatory and investment confidence, bringing innovative therapies to patients more efficiently.
Who we are
We are a strategic consulting firm leveraging 25 years of experience in the design and implementation of translational clinical pharmacology and model-informed drug development strategies to enhance project, portfolio, and patient value.
Our experience spans a wide range of successful accomplishments across a large variety of therapeutic modalities in multiple therapy areas and across all stages of research and development.
What we do
We partner with biotech and pharma to embed Quantitative Medicine approaches into every stage of drug development. Our services include:
Quantitative and clinical pharmacology strategy development and implementation
Dose selection, dose optimization, biomarker strategy and clinical trial design
Human dose prediction and translational pharmacology strategies
Regulatory and investor support
Capability building through leadership, vendor oversight, and training
Delivered through flexible, fractional, and/or on-demand engagements.
Why we do it
Drug development is complex, costly, and uncertain. Too often, important development decisions are made with fragmented or incomplete evidence. We believe that Quantitative Medicine, integrating PKPD principles and biological understanding, can turn data into clarity, such as optimizing dose selection, better predicting treatment outcomes, and assessing potential for differentation. This enables totality-of-evidence-based decisions that reduce risk, accelerate development and ultimately improve patient outcomes.